A detailed history of Amalgamated Bank transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 2,766 shares of SNDX stock, worth $36,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,766
Previous 2,766 -0.0%
Holding current value
$36,179
Previous $57,000 7.02%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$18.82 - $23.79 $1,994 - $2,521
106 Added 3.98%
2,766 $57,000
Q1 2024

Apr 23, 2024

SELL
$19.71 - $24.57 $120,782 - $150,564
-6,128 Reduced 69.73%
2,660 $63,000
Q4 2023

Feb 06, 2024

SELL
$11.39 - $21.67 $2,676 - $5,092
-235 Reduced 2.6%
8,788 $190,000
Q2 2023

Aug 11, 2023

BUY
$19.35 - $22.31 $48,026 - $55,373
2,482 Added 37.95%
9,023 $188,000
Q1 2023

May 02, 2023

SELL
$20.66 - $28.98 $12,540 - $17,590
-607 Reduced 8.49%
6,541 $138,000
Q3 2022

Nov 09, 2022

BUY
$18.51 - $24.79 $3,924 - $5,255
212 Added 3.06%
7,148 $172,000
Q2 2022

Aug 15, 2022

BUY
$13.64 - $19.48 $14,403 - $20,570
1,056 Added 17.96%
6,936 $133,000
Q1 2022

Jun 30, 2022

BUY
$14.84 - $22.15 $87,259 - $130,241
5,880 New
5,880 $102,000

Others Institutions Holding SNDX

About Syndax Pharmaceuticals Inc


  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $740M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.